Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • john_gamble
    Junior Member
    • Feb 2017
    • 2

    #1

    Advice RNA-Seq experimental design

    Hello,

    I've recently started working in a group that would like to start doing RNA-Seq experiments in order to compare the transcriptomes of pancreatic islets undergoing different treatments.

    As I'm new to this kind of work, I was wondering if anyone could offer advice on experimental design - specifically, how do you choose the correct number of samples (technical and biological replicates) and the depth of sequencing to give statistically meaningful results? Is it necessary to carry out a 'power' analysis to answer these questions? If so, how do you do that?

    I've spent some time going through the literature on this, but frankly, it's quite confusing and seems inaccessible to anyone without a background in advanced maths or statistics. (I have neither.)

    However, on the basis of what I've read, I've decided to run a pilot sequencing experiment with a limited number of samples and then enter the data into the 'Scotty' web-tool as described here:



    This then returns information on number of samples and read-depth required to achieve a specific statistical 'power'.

    Does that sound like a reasonable course of action?

    Any advice on this matter would be much appreciated. In fact, any advice, or pointers to worthwhile reading material/resources in the area of RNA-Seq difference analysis would be a huge help.

    Thanks for any advice offered.

    Regards,

    John

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    10-30-2026, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
32 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
71 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...